— Know what they know.
Not Investment Advice

PTHS AMEX

Pelthos Therapeutics Inc.
1W: -7.2% 1M: -17.7% 3M: -15.3% YTD: -30.1% 1Y: -23.7%
$20.60
+0.25 (+1.23%)
 
Weekly Expected Move ±10.3%
$16 $18 $21 $23 $25
AMEX · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $71.6M mcap · 1M float · 4.45% daily turnover · Short 65% of daily vol

Balance Sheet Trends

Total Assets
$130M +9424.0% ▲
3Y CAGR: +1232.8%
Total Liabilities
$92M +2141.3% ▲
3Y CAGR: +189.8%
Shareholders Equity
$39M +1532.6% ▲
Cash & Investments
$18M +3410.2% ▲
3Y CAGR: +589.1%
Total Debt
$35M +1493.2% ▲
3Y CAGR: +300.9%
Net Debt
$17M +904.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025
— Assets —
Cash$55K$96K$513K$18M
Short-Term Investments$0$0$0$0
Cash & ST Investments$55K$96K$513K$18M
Net Receivables$0$0$40K$9M
Inventory$0$0$0$24M
Other Current Assets$0$0$750K$419K
Total Current Assets$55K$96K$1M$53M
Property, Plant & Equip.$0$0$0$13M
Goodwill & Intangibles$0$0$0$64M
Long-Term Investments$0$0$0$0
Other Non-Current Assets$0$0$0$711K
Total Non-Current Assets$0$0$0$78M
Total Assets$55K$96K$1M$130M
— Liabilities —
Accounts Payable$3M$5M$2M$3M
Short-Term Debt$540K$1M$2M$635K
Deferred Revenue$0$0$0$966K
Other Current Liabilities$222K$646K$0$21M
Total Current Liabilities$4M$7M$4M$26M
Long-Term Debt$0$0$0$31M
Other Non-Current Liab.$0$0$0$30M
Total Non-Current Liabilities$0$0$0$66M
Total Liabilities$4M$7M$4M$92M
— Equity —
Common Stock$111$391$613$0
Retained Earnings-$6M-$14M-$21M-$65M
Accumulated OCI$0$0$0$0
Total Stockholders Equity-$4M-$6M-$3M$39M
Total Liabilities & Equity$55K$96K$1M$130M
— Key Metrics —
Total Debt$540K$1M$2M$35M
Net Debt$485K$1M$2M$17M
Total Investments$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms